KAPA

Kairos Pharma
KAPA

10 hedge funds and large institutions have $173K invested in Kairos Pharma in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$45.7K
2
+$9.86K
3
+$9.63K
4
UBS Group
UBS Group
Switzerland
+$4.85K
5
Citigroup
Citigroup
New York
+$4K

Top Sellers

1
-$1.31M
2
-$45.1K
3
-$12.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$49.6K
2
$44.5K
3
$31.4K
4
$15.5K
5
$9.61K
6
$9K
7
$6.71K
8
$3.9K
9
$2.69K
10
$36
11
–
12
–
13
–